Skip to main content

Market Overview

FDA To Hold AdCom Meeting For Expanding Use COVID-19 Vaccine In Children

FDA To Hold AdCom Meeting For Expanding Use COVID-19 Vaccine In Children
  • The FDA’s Center for Biologics Evaluation and Research (CBER) will convene a virtual meeting of the Vaccines and Related Biological Products Advisory Committee on June 10
  • The virtual meeting will provide a status update on its approach to expand the emergency use authorization (EUA) of COVID-19 vaccines to those aged 12 – 15 years, the regulator said in a press release.
  • The meeting will also discuss the data required to support a EUA and a biologics license application (BLA) for COVID-19 vaccines to children less than 12 years old.
  • Any specific product will not be discussed, the agency said.
  • “We want to ensure that the public has a clear understanding of our expectations for the data and information needed to support requests for emergency use authorization and biologics license applications for vaccines intended to prevent COVID-19 in this pediatric age range,” FDA said.

Related Articles (AZN + BNTX)

View Comments and Join the Discussion!

Posted-In: Briefs COVID-19 VaccineBiotech Government News Health Care FDA General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at